Table 2.
Author(s), year | Aim | ka | Sample size | Measuring instrument | Effect size | I2 | kadj | ||
|
|
|
|
|
Effect size | 95% CI (LLb to ULc) | P value |
|
|
Gibbons et al, 2016 [23] | Effects of VRd on lower limb outcomes in stroke patients | 9 | EGe: 104; CGf: 95 | BBSg, FRTh | 0.42 | 0.11 to 0.73 | .42 | 10 | 4.077 |
Iruthayarajah et al, 2017 [24] | To evaluate the effectiveness of VR interventions in improving balance in a chronic stroke population | 12 | EG: 132; CG: 142 | BBS | 0.506 | 0.259 to 0.753 | ≤.001 | 2.622 | 5.012 |
Mohammadi et al, 2019 [25] | To evaluate the effect of VR on balance as compared with that of conventional therapy alone poststroke | 13 | EG: 161; CG: 153 | BBS, FRT, PASi | 0.64 | 0.36 to 0.92 | .083 | 36.7 | 5.530 |
Liang et al, 2020 [26] | To evaluate the effectiveness of VR technology in promoting balance and walking function rehabilitation in stroke | 17 | EG: 215; CG: 217 | FRT, PAS | 4.09 | 2.20 to 5.97 | ≤.001 | 84.5 | 8.513 |
ak: number of primary studies.
bLL: lower limit.
cUL: upper limit.
dVR: virtual reality.
eEG: experimental group.
fCG: control group.
gBBS: Berg Balance Scale.
hFRT: functional reach test.
iPAS: Postural Assessment Scale.